Kidney Transplant Rejection Therapeutics Market
The market is growing due to increasing transplant procedures and demand for advanced immunosuppressants. Key players like Novartis, Pfizer, and CSL Behring are developing novel therapies to reduce rejection rates and improve long-term graft survival. Diagnostic advancements in biomarker monitoring further support personalized treatment approaches.
Access Full Report:
https://www.delveinsight.com/i....nfographics/kidney-t
Comment
Share
